Product Details
| Product Name:
IMP-1088 |
CAS No.:
2059148-82-0 |
| Purity:
99.52% |
Supply Ability:
10g |
| Release date:
2025/11/09 |
Product Introduction
Bioactivity
| Name | IMP-1088 |
| Description | IMP-1088 is a potent inhibitor of human N-myristoyltransferases NMT1 and NMT2 dual. |
| In vitro | IMP-1088 (1-1000 nM) inhibits production of infectious virus and single-cycle replication in primary human bronchial epithelial cells (hBEC) infected with rhinovirus RV-A1 (MOI 5) for 7 hours, and remains effective even when administered up to 3 hours post-infection[1]. Additionally, IMP-1088 (500 nM) blocks virus assembly and inhibits production of infectious rhinovirus particles in HeLa cells infected with rhinovirus RV-A16 (MOI 20) for 6 hours[1]. |
| Storage | store at low temperature | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 3.3 mg/mL (7.28 mM), Sonication is recommended.
DMSO : 95 mg/mL (209.47 mM), Sonication is recommended.
|
| Keywords | VP0 | virus-encoded | RV-A16 | RNASynthesis | RNA Synthesis | rhinovirus | replication | protein | N-myristoyltransferases | N-myristoyltransferase-1 (NMT-1) | NMT2 | NMT1 | Inhibitor | inhibit | IMP-1088 | IMP1088 | IMP 1088 | human | HsNMT2 | HsNMT1 | HeLa | hBEC | epithelial | DNASynthesis | DNA/RNA Synthesis | DNA Synthesis | bronchial |
| Inhibitors Related | 5-Fluorouracil | Quinizarin | Adenine hemisulfate | Procaine | Rifaximin | Capecitabine | Ribavirin | Guanidine hydrochloride | Methotrexate disodium | Thymidine | Cisplatin | Folic acid |
| Related Compound Libraries | DNA Damage & Repair Compound Library | Bioactive Compound Library | Anti-Viral Compound Library | Inhibitor Library | NO PAINS Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Fluorochemical Library | Cell Cycle Compound Library | Anti-Cancer Compound Library | Anti-Infection Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
-
CAS:1458674-25-3
$1320.00 / 25mg
-
CAS:2383117-96-0
$156.00 / 1mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$1980.00/50mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-08-21 |
|
|
$10.00/1KG |
VIP7Y
|
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-11-15 |
|
|
$0.00/25KG |
VIP6Y
|
Sichuan Zhuoyu Yantang Technology Co., Ltd.
|
2025-08-15 |
United States